Randomized Controlled Phase 2 Clinical Trial of JPH203 in Patients With Advanced Biliary Tract Cancers.
Phase 2
- Conditions
- Advanced Biliary Tract Cancers
- Registration Number
- JPRN-UMIN000034080
- Lead Sponsor
- J-Pharma Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 106
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patient with severe disorders and/or unstable complications except cancers evaluated by investigator. 2) Patient with infection required systemic therapy. 3) Patient with positive HIV-1 antibody or HBs antigen or HCV-RNA. 4) Patient with ECG abnormality 5) Patient with pleural fluids, pericardial effusions or ascites required drainage
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Progression Free Survival (PFS) by blinded independent central review
- Secondary Outcome Measures
Name Time Method